{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:47:05Z","timestamp":1791935225988,"version":"4.3.4"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,29]]},"DOI":"10.1093\/neuonc\/nox112","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T11:08:06Z","timestamp":1497092886000},"page":"1576-1587","source":"Crossref","is-referenced-by-count":213,"title":["PET imaging in patients with meningioma\u2014report of the RANO\/PET Group"],"prefix":"10.1093","volume":"19","author":[{"given":"Norbert","family":"Galldiks","sequence":"first","affiliation":[{"name":"Department of Neurology, University Hospital Cologne, Cologne, Germany"},{"name":"Institute of Neuroscience and Medicine, Research Center Juelich, Juelich, Germany"},{"name":"Center of Integrated Oncology, Universities of Cologne and Bonn, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie L","family":"Albert","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine, Ludwig Maximilians-University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sommerauer","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Zurich, Zurich, Switzerland"},{"name":"Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca L","family":"Grosu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Hospital Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Ganswindt","sequence":"additional","affiliation":[{"name":"Departments of Radiation Oncology, Ludwig Maximilians-University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Law","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Preusser","sequence":"additional","affiliation":[{"name":"Department of Medicine I and Comprehensive Cancer Centre CNS Tumours Unit, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Le Rhun","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Vogelbaum","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Dhermain","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Gustave Roussy University Hospital, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Josef","family":"Langen","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Medicine, Research Center Juelich, Juelich, Germany"},{"name":"Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg C","family":"Tonn","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery, Ludwig Maximilians-University of Munich, Munich, Germany"},{"name":"German Cancer Consortium, Partner Sites, Freiburg and Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,12]]},"reference":[{"issue":"6","key":"key\n\t\t\t\t20180320095316_CIT0001","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"12","key":"key\n\t\t\t\t20180320095316_CIT0002","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","article-title":"Histological classification and molecular genetics of meningiomas","volume":"5","author":"Riemenschneider","year":"2006","journal-title":"Lancet Neurol"},{"issue":"3","key":"key\n\t\t\t\t20180320095316_CIT0003","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11060-010-0343-1","article-title":"Intracranial meningiomas of atypical (WHO grade II) histology","volume":"99","author":"Rogers","year":"2010","journal-title":"J Neurooncol"},{"issue":"5","key":"key\n\t\t\t\t20180320095316_CIT0004","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv377","article-title":"TERT Promoter mutations and risk of recurrence in meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"key\n\t\t\t\t20180320095316_CIT0005","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"issue":"9","key":"key\n\t\t\t\t20180320095316_CIT0006","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol"},{"issue":"5","key":"key\n\t\t\t\t20180320095316_CIT0007","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/neuonc\/nov316","article-title":"Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma","volume":"18","author":"Abedalthagafi","year":"2016","journal-title":"Neuro Oncol"},{"issue":"3","key":"key\n\t\t\t\t20180320095316_CIT0008","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Brastianos","year":"2013","journal-title":"Nat Genet"},{"issue":"6123","key":"key\n\t\t\t\t20180320095316_CIT0009","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"issue":"3","key":"key\n\t\t\t\t20180320095316_CIT0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","article-title":"Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations","volume":"125","author":"Reuss","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"9","key":"key\n\t\t\t\t20180320095316_CIT0011","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/neuonc\/now058","article-title":"Response Assessment in Neuro-Oncology Working Group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas","volume":"18","author":"Albert","year":"2016","journal-title":"Neuro Oncol"},{"issue":"11","key":"key\n\t\t\t\t20180320095316_CIT0012","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/neuonc\/nov118","article-title":"From the clinician\u2019s point of view\u2014what is the status quo of positron emission tomography in patients with brain tumors","volume":"17","author":"Galldiks","year":"2015","journal-title":"Neuro Oncol"},{"issue":"7","key":"key\n\t\t\t\t20180320095316_CIT0013","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.crad.2010.01.003","article-title":"FDG PET\/CT in oncology: \u201craising the bar\u201d","volume":"65","author":"Patel","year":"2010","journal-title":"Clin Radiol"},{"issue":"10","key":"key\n\t\t\t\t20180320095316_CIT0014","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s00259-009-1133-x","article-title":"18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma","volume":"36","author":"Lee","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"key\n\t\t\t\t20180320095316_CIT0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1148\/radiology.164.2.3496626","article-title":"Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study","volume":"164","author":"Di Chiro","year":"1987","journal-title":"Radiology"},{"issue":"1","key":"key\n\t\t\t\t20180320095316_CIT0016","first-page":"26","article-title":"Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET","volume":"38","author":"Cremerius","year":"1997","journal-title":"J Nucl Med"},{"issue":"1","key":"key\n\t\t\t\t20180320095316_CIT0017","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiology.195.1.7892494","article-title":"Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET","volume":"195","author":"Delbeke","year":"1995","journal-title":"Radiology"},{"issue":"6","key":"key\n\t\t\t\t20180320095316_CIT0018","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2967\/jnumed.109.070565","article-title":"1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery","volume":"51","author":"Liu","year":"2010","journal-title":"J Nucl Med"},{"issue":"5","key":"key\n\t\t\t\t20180320095316_CIT0019","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.0.CO;2-S","article-title":"Expression of somatostatin receptor subtypes in human brain tumors","volume":"76","author":"Dutour","year":"1998","journal-title":"Int J Cancer"},{"issue":"2","key":"key\n\t\t\t\t20180320095316_CIT0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1210\/jcem-63-2-433","article-title":"High incidence of somatostatin receptors in human meningiomas: biochemical characterization","volume":"63","author":"Reubi","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180320095316_CIT0021","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00401-015-1459-3","article-title":"Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen","volume":"130","author":"Menke","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"14","key":"key\n\t\t\t\t20180320095316_CIT0022","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2217\/fon.14.139","article-title":"PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature","volume":"10","author":"Johnbeck","year":"2014","journal-title":"Future Oncol"},{"issue":"3","key":"key\n\t\t\t\t20180320095316_CIT0023","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2967\/jnumed.114.149120","article-title":"Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue","volume":"56","author":"Rachinger","year":"2015","journal-title":"J Nucl Med"},{"issue":"9","key":"key\n\t\t\t\t20180320095316_CIT0024","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00259-012-2155-3","article-title":"Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET\/CT and contrast-enhanced MRI","volume":"39","author":"Afshar-Oromieh","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"key\n\t\t\t\t20180320095316_CIT0025","first-page":"1053","article-title":"PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas","volume":"42","author":"Henze","year":"2001","journal-title":"J Nucl Med"},{"issue":"11","key":"key\n\t\t\t\t20180320095316_CIT0026","doi-asserted-by":"crossref","first-page":"e111624","DOI":"10.1371\/journal.pone.0111624","article-title":"Meningiomas: a comparative study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for molecular imaging in mice","volume":"9","author":"Soto-Montenegro","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"key\n\t\t\t\t20180320095316_CIT0027","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00259-010-1512-3","article-title":"Procedure guidelines for PET\/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE","volume":"37","author":"Virgolini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"key\n\t\t\t\t20180320095316_CIT0028","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00259-012-2109-9","article-title":"MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET","volume":"39","author":"Jansen","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t20180320095316_CIT0029","doi-asserted-by":"crossref","first-page":"372509","DOI":"10.1155\/2011\/372509","article-title":"The clinical value of PET with amino acid tracers for gliomas WHO grade II","volume":"2011","author":"Smits","year":"2011","journal-title":"Int J Mol Imaging"},{"issue":"12","key":"key\n\t\t\t\t20180320095316_CIT0030","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2967\/jnumed.113.123836","article-title":"Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma","volume":"54","author":"Galldiks","year":"2013","journal-title":"J Nucl Med"},{"issue":"4","key":"key\n\t\t\t\t20180320095316_CIT0031","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ijrobp.2008.02.058","article-title":"Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas","volume":"72","author":"Astner","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"key\n\t\t\t\t20180320095316_CIT0032","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00259-014-2934-0","article-title":"Uptake and tracer kinetics of O-(2-(18)F-fluoroethyl)-L-tyrosine in meningiomas: preliminary results","volume":"42","author":"Cornelius","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"key\n\t\t\t\t20180320095316_CIT0033","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00259-001-0690-4","article-title":"Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET","volume":"29","author":"Chung","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"key\n\t\t\t\t20180320095316_CIT0034","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-011-0759-2","article-title":"Clinical characteristics of meningiomas assessed by 11C-methionine and 18F-fluorodeoxyglucose positron-emission tomography","volume":"107","author":"Arita","year":"2012","journal-title":"J Neurooncol"},{"issue":"7","key":"key\n\t\t\t\t20180320095316_CIT0035","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/neuonc\/now001","article-title":"68Gallium-DOTATATE PET in meningioma: a reliable predictor of tumor growth rate","volume":"18","author":"Sommerauer","year":"2016","journal-title":"Neuro Oncol"},{"issue":"4","key":"key\n\t\t\t\t20180320095316_CIT0036","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1227\/NEU.0b013e31823bcd87","article-title":"Positron emission tomography imaging of meningioma in clinical practice: review of literature and future directions","volume":"70","author":"Cornelius","year":"2012","journal-title":"Neurosurgery"},{"issue":"4","key":"key\n\t\t\t\t20180320095316_CIT0037","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3171\/2013.5.JNS122204","article-title":"Boron neutron capture therapy for recurrent high-grade meningiomas","volume":"119","author":"Kawabata","year":"2013","journal-title":"J Neurosurg"},{"issue":"4","key":"key\n\t\t\t\t20180320095316_CIT0038","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1215\/15228517-2008-107","article-title":"Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas","volume":"11","author":"Miyatake","year":"2009","journal-title":"Neuro Oncol"},{"issue":"4","key":"key\n\t\t\t\t20180320095316_CIT0039","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.urolonc.2010.08.008","article-title":"Imaging of prostate cancer with PET\/CT and radioactively labeled choline derivates","volume":"31","author":"Krause","year":"2013","journal-title":"Urol Oncol"},{"issue":"4","key":"key\n\t\t\t\t20180320095316_CIT0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrurol.2016.26","article-title":"Current use of PSMA-PET in prostate cancer management","volume":"13","author":"Maurer","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"1","key":"key\n\t\t\t\t20180320095316_CIT0041","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/RLU.0b013e31818f4369","article-title":"C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: an initial experience","volume":"34","author":"Giovacchini","year":"2009","journal-title":"Clin Nucl Med"},{"issue":"3","key":"key\n\t\t\t\t20180320095316_CIT0042","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1097\/RLU.0000000000000287","article-title":"Diagnosis of complex renal cystic masses and solid renal lesions using PET imaging: comparison of 11C-acetate and 18F-FDG PET imaging","volume":"39","author":"Oyama","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"4","key":"key\n\t\t\t\t20180320095316_CIT0043","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7150\/thno.10760","article-title":"Kinetic analysis of dynamic (11)C-acetate PET\/CT imaging as a potential method for differentiation of hepatocellular carcinoma and benign liver lesions","volume":"5","author":"Huo","year":"2015","journal-title":"Theranostics"},{"issue":"8","key":"key\n\t\t\t\t20180320095316_CIT0044","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/bju.12279","article-title":"Application of C-11-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature","volume":"112","author":"Mohsen","year":"2013","journal-title":"BJU Int"},{"issue":"2","key":"key\n\t\t\t\t20180320095316_CIT0045","first-page":"181","article-title":"11C-acetate PET imaging of prostate cancer","volume":"43","author":"Oyama","year":"2002","journal-title":"J Nucl Med"},{"issue":"2","key":"key\n\t\t\t\t20180320095316_CIT0046","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1148\/radiol.14132118","article-title":"Multimodal approach to detect osseous involvement in meningioma: additional value of (18)F-fluoride PET\/CT for conventional imaging","volume":"273","author":"Tateishi","year":"2014","journal-title":"Radiology"},{"issue":"3","key":"key\n\t\t\t\t20180320095316_CIT0047","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1097\/RLU.0b013e318279fd79","article-title":"18F-fluoride PET\/CT allows detection of hyperostosis and osseous involvement in meningioma: initial experience","volume":"38","author":"Tateishi","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"1","key":"key\n\t\t\t\t20180320095316_CIT0048","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/RLU.0000000000000407","article-title":"Sphenoid wing meningioma behavior on 11C-PiB and 18F-FDG PET","volume":"40","author":"Chaves","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"12","key":"key\n\t\t\t\t20180320095316_CIT0049","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/RLU.0000000000001406","article-title":"Incidental meningioma mimicking metastasis of prostate adenocarcinoma in 68Ga-labeled PSMA ligand PET\/CT","volume":"41","author":"Bilgin","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"1","key":"key\n\t\t\t\t20180320095316_CIT0050","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/RLU.0b013e3182815d16","article-title":"The incidental suggestive meningioma presenting as high 18F FP-CIT uptake on PET\/CT study","volume":"39","author":"Song","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"9420","key":"key\n\t\t\t\t20180320095316_CIT0051","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(04)16153-9","article-title":"Meningiomas","volume":"363","author":"Whittle","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"key\n\t\t\t\t20180320095316_CIT0052","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1053\/hupa.2002.129200","article-title":"Dural lesions mimicking meningiomas","volume":"33","author":"Johnson","year":"2002","journal-title":"Hum Pathol"},{"issue":"1","key":"key\n\t\t\t\t20180320095316_CIT0053","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/01676830.2014.959185","article-title":"Ga-68-DOTA-TATE PET\/CT for discrimination of tumors of the optic pathway","volume":"34","author":"Klingenstein","year":"2015","journal-title":"Orbit"},{"issue":"7","key":"key\n\t\t\t\t20180320095316_CIT0054","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/01616412.1999.11740989","article-title":"Glucose and methionine uptake and proliferative activity in meningiomas","volume":"21","author":"Iuchi","year":"1999","journal-title":"Neurol Res"},{"issue":"8","key":"key\n\t\t\t\t20180320095316_CIT0055","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s12149-013-0747-z","article-title":"Analysis of progression and recurrence of meningioma using (11)C-methionine PET","volume":"27","author":"Ikeda","year":"2013","journal-title":"Ann Nucl Med"},{"issue":"1","key":"key\n\t\t\t\t20180320095316_CIT0056","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2005.12.006","article-title":"Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET","volume":"65","author":"Milker-Zabel","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"key\n\t\t\t\t20180320095316_CIT0057","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00259-009-1270-2","article-title":"Potential impact of (68)Ga-DOTATOC PET\/CT on stereotactic radiotherapy planning of meningiomas","volume":"37","author":"Nyuyki","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"key\n\t\t\t\t20180320095316_CIT0058","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2967\/jnumed.106.038216","article-title":"PET\/CT of skull base meningiomas using 2-18F-fluoro-L-tyrosine: initial report","volume":"48","author":"Rutten","year":"2007","journal-title":"J Nucl Med"},{"issue":"2","key":"key\n\t\t\t\t20180320095316_CIT0059","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2006.02.047","article-title":"11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy","volume":"66","author":"Grosu","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"key\n\t\t\t\t20180320095316_CIT0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","article-title":"Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review","volume":"122","author":"Rogers","year":"2015","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t20180320095316_CIT0061","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.117.191932","article-title":"Improved detection of transosseous meningiomas using 68Ga-DOTATATE PET-CT compared to contrast-enhanced MRI","author":"Kunz","year":"2017","journal-title":"J Nucl Med"},{"issue":"5","key":"key\n\t\t\t\t20180320095316_CIT0062","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3171\/2015.5.JNS15330","article-title":"Orbit-associated tumors: navigation and control of resection using intraoperative computed tomography","volume":"124","author":"Terpolilli","year":"2016","journal-title":"J Neurosurg"},{"issue":"5","key":"key\n\t\t\t\t20180320095316_CIT0063","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0360-3016(03)00279-7","article-title":"Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience","volume":"56","author":"Grosu","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20180320095316_CIT0064","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1748-717X-4-56","article-title":"[68Ga]-DOTATOC-PET\/CT for meningioma IMRT treatment planning","volume":"4","author":"Gehler","year":"2009","journal-title":"Radiat Oncol"},{"issue":"1","key":"key\n\t\t\t\t20180320095316_CIT0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2012.03.021","article-title":"Contribution of 68Ga-DOTATOC PET\/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy","volume":"85","author":"Graf","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"key\n\t\t\t\t20180320095316_CIT0066","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s002590000335","article-title":"Evaluation of the effect of high-energy proton irradiation treatment on meningiomas by means of 11C-L-methionine PET","volume":"27","author":"Gudjonsson","year":"2000","journal-title":"Eur J Nucl Med"},{"issue":"8","key":"key\n\t\t\t\t20180320095316_CIT0067","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s00259-016-3310-z","article-title":"Long-term evaluation of the effect of hypofractionated high-energy proton treatment of benign meningiomas by means of (11)C-L-methionine positron emission tomography","volume":"43","author":"Ryttlefors","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"key\n\t\t\t\t20180320095316_CIT0068","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2967\/jnumed.115.161158","article-title":"Radiopeptides for imaging and therapy: a radiant future","volume":"56","author":"Chatalic","year":"2015","journal-title":"J Nucl Med"},{"issue":"11","key":"key\n\t\t\t\t20180320095316_CIT0069","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s002590050476","article-title":"Yttrium-90 DOTATOC: first clinical results","volume":"26","author":"Otte","year":"1999","journal-title":"Eur J Nucl Med"},{"issue":"9","key":"key\n\t\t\t\t20180320095316_CIT0070","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-009-1115-z","article-title":"Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma","volume":"36","author":"Bartolomei","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"key\n\t\t\t\t20180320095316_CIT0071","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/cbr.2013.1599","article-title":"Peptide receptor radionuclide therapy in patients with inoperable meningiomas: our experience and review of the literature","volume":"29","author":"Minutoli","year":"2014","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"key\n\t\t\t\t20180320095316_CIT0072","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2967\/jnumed.114.147256","article-title":"Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial","volume":"56","author":"Marincek","year":"2015","journal-title":"J Nucl Med"},{"issue":"11","key":"key\n\t\t\t\t20180320095316_CIT0073","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.2967\/jnumed.115.155853","article-title":"90Y-DOTATOC as a therapeutic option for complex recurrent or progressive meningiomas","volume":"56","author":"Gerster-Gilli\u00e9ron","year":"2015","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20180320095316_CIT0074","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1748-717X-7-99","article-title":"Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma","volume":"7","author":"Kreissl","year":"2012","journal-title":"Radiat Oncol"},{"key":"key\n\t\t\t\t20180320095316_CIT0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1748-717X-6-94","article-title":"Successful radiopeptide targeting of metastatic anaplastic meningioma: case report","volume":"6","author":"Sabet","year":"2011","journal-title":"Radiat Oncol"},{"issue":"10","key":"key\n\t\t\t\t20180320095316_CIT0076","first-page":"1599","article-title":"Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma","volume":"47","author":"van Essen","year":"2006","journal-title":"J Nucl Med"},{"issue":"11","key":"key\n\t\t\t\t20180320095316_CIT0077","first-page":"1538","article-title":"Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE\/-TOC uptake","volume":"18","author":"Seystahl","year":"2016","journal-title":"Neuro Oncol"},{"issue":"11","key":"key\n\t\t\t\t20180320095316_CIT0078","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1007\/s00259-014-2857-9","article-title":"\u00b2\u00b9\u00b3Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience","volume":"41","author":"Kratochwil","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"key\n\t\t\t\t20180320095316_CIT0079","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-001-0717-x","article-title":"Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study","volume":"29","author":"Schumacher","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/19\/12\/1576\/24419114\/nox112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T14:21:27Z","timestamp":1521555687000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/19\/12\/1576\/3866973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,12]]},"references-count":79,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,6,12]]},"published-print":{"date-parts":[[2017,11,29]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nox112","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12]]},"published":{"date-parts":[[2017,6,12]]}}}